Trial intelligence / Profile preview

Pimecrolimus Cream for Oral Erosive Lichen Planus

NCT00321750Phase 2Terminated

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Dec 2004
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in oral lichen planus (OLP) (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoints: 12-point clinical score at 4 weeks and Blood level of pimecrolimus at Day 28. Started Dec 2004; status: terminated.

02

Drugs

Pimecrolimus vehicle + topical corticosteroid
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT00321750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00321750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call